Premium
Effects of glucosamine supplements on painful temporomandibular joint osteoarthritis: A systematic review
Author(s) -
Melo G.,
Casett E.,
StuginskiBarbosa J.,
Guerra E. N. S.,
Fernandes D. A.,
Porporatti A. L.,
FloresMir C.,
De Luca Canto G.
Publication year - 2018
Publication title -
journal of oral rehabilitation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.991
H-Index - 93
eISSN - 1365-2842
pISSN - 0305-182X
DOI - 10.1111/joor.12616
Subject(s) - medicine , placebo , osteoarthritis , ibuprofen , meta analysis , randomized controlled trial , physical therapy , clinical trial , glucosamine , relative risk , confidence interval , alternative medicine , pharmacology , chemistry , organic chemistry , pathology
Summary The purpose of this study was to systematically review the literature for studies that assessed the effects of glucosamine supplements ( GS ) on pain and maximum mouth opening ( MMO ) restriction compared to other therapies, placebo or no intervention on painful temporomandibular joint osteoarthritis ( TMJ OA ). Randomised controlled trials were selected in a two‐phase process. Seven electronic databases, in addition to three grey literature databases, were searched. Risk of bias was assessed using the Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Twelve potentially eligible studies were identified, from which three were finally included. Furthermore, two were categorised at low risk and one at high risk of bias. Intervention groups were treated with glucosamine‐sulphate, while controls were treated with placebo or ibuprofen. In two studies, GS were equally effective regarding pain reduction and mouth opening improvement compared to ibuprofen taken two or three times a day over 12 weeks; however, one study did not find significant differences in follow‐up evaluations concerning these clinical variables in both glucosamine and placebo groups administered over six weeks. There is very low evidence regarding GS therapeutic effects on TMJ OA . Considering a follow‐up of 12 weeks, GS were as effective as ibuprofen taken two or three times a day. However, over six weeks of medication intake, GS were not superior to placebo. Still, included studies presented major drawbacks, and therefore, conclusions must be interpreted with caution.